[Osteoporosis caused by pediatric diseases].
Naiki
Yasuhiro
Y
Division of Endocrinology and Metabolism, National Center for Child Health and Development.
Tanaka
Toshiaki
T
D000856:Anorexia Nervosa / Q000150:complications; D015519:Bone Density; D002118:Calcium / Q000008:administration & dosage; D002648:Child; D004164:Diphosphonates / Q000008:administration & dosage; D007987:Gonadotropin-Releasing Hormone / Q000009:adverse effects / Q000031:analogs & derivatives; D019382:Human Growth Hormone / Q000172:deficiency; D006801:Humans; D007006:Hypogonadism / Q000150:complications; D010013:Osteogenesis Imperfecta / Q000150:complications* / Q000235:genetics; D010024:Osteoporosis / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D011239:Prednisolone / Q000009:adverse effects; D020845:Selective Estrogen Receptor Modulators / Q000008:administration & dosage; D014424:Turner Syndrome / Q000150:complications* / Q000235:genetics
D004164:Diphosphonates; D020845:Selective Estrogen Receptor Modulators; D019382:Human Growth Hormone; D007987:Gonadotropin-Releasing Hormone; D011239:Prednisolone; D002118:Calcium